Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Law Firm Appointed To Boost Fight Against NHS Fraud
A new partnership between NHS Counter Fraud and law firm Capsticks will strengthen support to health bodies seeking to recover NHS funds lost to fraud.
generic viagra online
Experts Disagree On Whether Healthy People Should Take Brain Boosting Drugs
It is unethical to stop healthy people from taking methylphenidate (Ritalin) to enhance their mental performance, says John Harris, Professor of Bioethics at the University of Manchester, in an article published on bmj.com today. He adds that society "ought to want [enhancement]" and that "it is not rational to be against human enhancement."
News of the day
President Obama Reverses Bush Policy Preventing Consumers From Suing Product Makers In State Courts
President Obama on Wednesday ordered federal agencies to rescind regulations enacted by former President George W. Bush"s administration that protect manufacturers of such products as medical devices from product-liability lawsuits in state court, the Wall Street Journal reports. The decision could affect a wide range of manufacturers and products because the Bush administration "aggressively" encouraged federal agencies to make rules that pre-empt and override state laws, which often meant protecting manufacturers of medical equipment from lawsuits, according to the Journal. Obama in a two-page memo wrote that federal agencies and departments could claim state law is pre-empted by federal law only when there is a well-defined legal basis. The memo stated that state laws are important because they supplement federal regulations. "State and local governments have frequently protected health, safety and environment more aggressively than has the national government," Obama wrote (Mundy/Kendall, Wall Street Journal, 5/21). Obama ordered agencies to review regulations from the past decade and look for possible occasions in which the government improperly declared federal pre-emption (Yost, AP/Kansas City Star, 5/20). According to the Journal, business groups oppose the decision (Wall Street Journal, 5/21).
Public Health

Magellan Spine Technologies Announces First Implant Of The DART Disc Annular Repair Technology For Lumbar Disc Herniations

Magellan Spine Technologies, Inc. announced the first human implant of its DART (Disc Annular Repair Technology) System for use after lumbar discectomy procedures. This initial clinical use follows European CE Mark clearance of the DART System in April 2009. This first of its kind implant was performed by Drs. Juan Dipp and Ricardo Flores at Hospital Y Centro Medico Del Prado in Tijuana, Mexico. Following a standard discectomy procedure for a lumbar disc herniation, the patient was implanted with the Magellan DART device. The device is designed to prevent recurrent disc herniation and maintain disc height. Commenting on the procedure Dr. Dipp stated, "The DART implantation did not alter the discectomy procedure and was easy to complete. Upon implantation, the DART device sealed the annular defect and increased the patient"s disc height. The patient was discharged less than 24 hours from surgery, has reported no pain and returned to normal activities within the first week." Dr. Dipp is an orthopedic surgeon and the principal investigator for the clinical evaluation of the Magellan DART device. The DART - Disc Annular Repair Technology The DART is a unique implant that provides a simple and quick seal of the annulus following a standard lumbar discectomy procedure. The unique design and implantation method of the DART provides distinct advantages over other non-fusion lumbar spinal implants. When implanted, the DART is placed near the central axis of rotation along the posterior edge of the vertebral body. The device is aligned with the vertebral body load column, the strongest of the three primary spinal vertical load columns and is secured in place at the apophyseal ring. The DART has structural integrity similar to interbody fusion devices and provides support to maintain disc height. Commenting on the first human implantation of Magellan"s DART System, Jeff Valko, Chief Executive Officer said, "We are very pleased with the acute results of the first implantation of the DART. The DART represents a novel step forward in the treatment of the spine. Magellan"s device will enable physicians to reduce the risk of reherniation and disc height loss which can lead to pain and degeneration of adjacent segments of the spine. The Company plans to initiate a limited European clinical evaluation late in 2009 followed by commercialization in 2010." Magellan Spine Technologies, Inc., incubated in 2007 by the MedFocus Fund, is a private medical technology firm located in Irvine, California. Magellan is developing products for intervertebral therapies including the DART System which provides disc annular repair and stabilization following lumbar spine discectomy procedures. Magellan Spine Technologies, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009